Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Sep;18(5):332-8.
doi: 10.1053/j.ackd.2011.03.005.

Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients

Jeremy Kiffel  1 , Yael Rahimzada, Howard Trachtman
Affiliations
Review

Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients

Jeremy Kiffel et al. Adv Chronic Kidney Dis. 2011 Sep.

Abstract

Focal segmental glomerulosclerosis (FSGS) is one of the most common forms of acquired glomerular disease leading to end-stage kidney disease. Its incidence is rising around the world. There is no proven therapy for those patients who do not respond to corticosteroids and it can recur in 20% to 25% of patients who receive a kidney transplant. The disease can be primary, or it can be secondary to various conditions including vesicoureteral reflux, obesity, medications, and infections. Recent advances have demonstrated the important role of genetic mutations in podocyte proteins as a cause of FSGS. There is an urgent need for randomized clinical trials to develop safe and effective therapy for FSGS that occurs in the native or transplanted kidney.

PubMed Disclaimer

References

    1. D’Agati V. Pathological classification of focal segmental glomerulosclerosis. Semin Nephrol. 2003;23:117–34. - PubMed
    1. Stokes MB, Valeri AM, Markowitz, D’Agati VD. Cellular focal segmental glomerulosclerosis: Clinical and pathologic features. Kidney Int. 2006;70:1783–92. - PubMed
    1. Chun MJ, Korbet SM, Schwartz MM, Lewis EJ. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol. 2004;15:2169–77. - PubMed
    1. Jennette JC, Hipp CG. C1q nephropathy; a distinct pathologic entity usually causing nephrotic syndrome. Am J Kid Dis. 1985;6:103–10. - PubMed
    1. Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D’Agati V. C1q nephropathy: A variant of focal segmental glomerulosclerosis. Kidney Int. 2003;64:1232–40. - PubMed

Substances